Our group showed that Jak2 inhibition by JSI-124 ameliorates pulmonary artery remodeling, increases pulmonary artery relaxation, and improves the overall symptoms of the disease in this experimental model of bleomycin-induced IPF with PH [9]. The gene discussed is JAK2; the disease is idiopathic pulmonary fibrosis.